Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 278, Issue 3, pp 231–246 | Cite as

Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidine

  • G. Haeusler
Article

Summary

Arterial blood pressure, heart rate and discharges in the preganglionic splanchnic and a postganglionic renal sympathetic nerve were recorded in cats anaesthetized with urethane. Electrical stimulation of the posterior hypothalamus or the fastigial nucleus of the cerebellum elicited an immediate increase in sympathetic nerve activity and a rise in blood pressure and heart rate. The stimulation-induced discharge pattern in the sympathetic nerves was characterized by a strong initial burst followed by a phase of inhibition and a final stabilization of the discharges at a level definitely lower than the initial burst. This pattern was reversibly converted into a constant high amplitude firing during a lowering of the blood pressure by bleeding the cats and irreversibly so after cutting the buffer nerves. These findings indicate that the inhibitory phase of the sympathetic discharge pattern during central stimulation is due to the rise in blood pressure and the ensuing baroreceptor-reflex activation.

Clonidine (0.03 and 0.1 mg/kg i.v.) reduced the spontaneous sympathetic nerve activity and lowered blood pressure and heart rate. The sympathetic discharges evoked by central stimulation were partially inhibited by clonidine, an effect which could be overcome by raising the voltage used for central stimulation. Independent of the strength of this stimulation an inhibitory phase in the evoked discharge pattern was not observed after clonidine, even when the low blood pressure due to the drug action was raised by a noradrenaline infusion. After clonidine, the evoked discharge pattern closely resembled that after simultaneous stimulation of both sinus nerves and the hypothalamus or the fastigial nucleus, and it was not altered by additional stimulation of the sinus nerves. These observations have led to the hypothesis that clonidine causes a long-lasting activation within an as yet unidentified part of the central pathway of the depressor baroreceptor reflex. In view of the well-known α-adrenoceptor stimulating property of clonidine, and since the central effect of clonidine was antagonized by the α-adrenoceptor blocking agent piperoxan, it is likely that the central part of the baroreceptor-reflex pathway is modified by or contains adrenergic neurones.

Key words

Clonidine Sympathetic Nerve Activity Blood Pressure Baroreceptor Reflex Central α-Adrenoceptors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Achari, N. K., Downman, C. B. B.: Autonomic effector responses to stimulation of nucleus fastigius. J. Physiol. (Lond.) 210, 637–650 (1970).Google Scholar
  2. Doba, N., Reis, D. J.: Changes in regional blood flow and cardiodynamics evoked by electrical stimulation of the fastigial nucleus in the cat and their similarity to orthostatic reflexes. J. Physiol. (Lond.) 227, 729–747 (1972).Google Scholar
  3. Green, J. H., Heffron, P. F.: Simultaneous recording of sympathetic activity in different regions. J. Physiol. (Lond.) 185, 48 P-50 P (1966).Google Scholar
  4. Haeusler, G.: Effects of α-adrenolytics on central cardiovascular control. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, R 27 (1973).Google Scholar
  5. Haeusler, G., Finch, L., Thoenen, H.: Central adrenergic neurones and the initiation and development of experimental hypertension. Experientia (Basel) 28, 1200–1203 (1972a).Google Scholar
  6. Haeusler, G., Gerold, M., Thoenen, H.: Cardiovascular effects of 6-hydroxydopamine injected into a lateral brain ventricle of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 211–228 (1972b).Google Scholar
  7. Haeusler, G., Haefely, W., Huerlimann, A.: On the mechanism of the adrenergic nerve blocking action of bretylium. Naunyn-Schmiedebergs Arch. Pharmak. 265, 260–277 (1969).Google Scholar
  8. Kobinger, W.: Über den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 258, 48–58 (1967).Google Scholar
  9. Kobinger, W., Walland, A.: Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl. Europ. J. Pharmacol. 2, 155–162 (1967).Google Scholar
  10. Miura, M., Reis, D. J.: Cerebellum: a pressor response elicited from the fastigial nucleus and its efferent pathway in brainstem. Brain Res. 13, 595–599 (1969).Google Scholar
  11. Miura, M., Reis, D. J.: A blood pressure response from fastigial nucleus and its relay pathway in brainstem. Amer. J. Physiol. 219, 1330–1336 (1970).Google Scholar
  12. Nakamura, K., Gerold, M., Thoenen, H.: Experimental hypertension of the rat: Reciprocal changes of norepinephrine turnover in heart and brainstem. Naunyn-Schmiedebergs Arch. Pharmak. 268, 125–139 (1971).Google Scholar
  13. Nayler, W. C., Price, J. M., Swann, J. B., McInnes, I., Race, D., Lowe, T. E.: Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation. J. Pharmacol. exp. Ther. 164, 45–59 (1968).Google Scholar
  14. Ninomiya, I., Judy, W. V., Wilson, M. F.: Hypothalamic stimulus effects on sympathetic nerve activity. Amer. J. Physiol. 218, 453–462 (1970).Google Scholar
  15. Philippu, A., Roensberg, W., Przuntek, H.: Pressor responses to hypothalamic stimulation as influenced by drugs affecting adrenergic receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, R 55 (1973).Google Scholar
  16. Pitts, R. F., Bronk, W. D.: Excitability cycle of the hypothalamus-sympathetic neurone system. Amer. J. Physiol. 135, 504–522 (1942).Google Scholar
  17. Pitts, R. F., Larrabee, M. G., Bronk, W. D.: An analysis of hypothalamic cardiovascular control. Amer. J. Physiol. 134, 359–383 (1941).Google Scholar
  18. Sattler, R. W., van Zwieten, P. A.: Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery. Europ. J. Pharmacol. 2, 9–13 (1967).Google Scholar
  19. Schmitt, H., Schmitt, H.: Localization of the hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan). Europ. J. Pharmacol. 6, 8–12 (1969).Google Scholar
  20. Schmitt, H., Schmitt, H.: Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapressan®) and α-adrenergic blocking drugs. Europ. J. Pharmacol. 9, 7–13 (1970).Google Scholar
  21. Schmitt, H., Schmitt, H., Boissier, J. R., Giudicelli, J. F.: Centrally mediated decrease in sympathetic tone induced by 2-(2,6-dichlorophenylamino)-2-imidazoline (S.T. 155, Catapresan). Europ. J. Pharmacol. 2, 147–148 (1967).Google Scholar
  22. Schmitt, H., Schmitt, H., Boissier, J. R., Giudicelli, J. F., Fichelle, J.: Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures. Europ. J. Pharmacol. 2, 340–346 (1968).Google Scholar
  23. Schmitt, H., Schmitt, H., Fenard, S.: Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxan. Europ. J. Pharmacol. 14, 98–100 (1971).Google Scholar
  24. Sherman, G. P., Grega, G. J., Woods, R. J., Buckley, J. P.: Evidence for a central hypotensive mechanism of 2-(2,6-dichlorophenylamino)-2-imidazoline (Catapresan, ST-155). Europ. J. Pharmacol. 2, 326–328 (1968).Google Scholar
  25. Snider, R. S., Niemer, W. T.: A stereotaxic atlas of the cat brain. Chicago: The University of Chicago Press 1961.Google Scholar

Copyright information

© Springer-Verlag 1973

Authors and Affiliations

  • G. Haeusler
    • 1
  1. 1.Department of Experimental MedicineF. Hoffmann-La Roche & Co., Ltd.BaselSwitzerland

Personalised recommendations